First, it is important to understand that hair loss (Hair Fall), thinning hair, and baldness are symptoms or clinical signs rather than diagnoses on their own. They can occur for many different reasons. This is similar to having a fever: treating the fever may relieve the symptom, but it does not necessarily address the underlying illness. Likewise, attempting to treat hair loss without identifying its cause may delay appropriate care, allowing some conditions to progress. If you are experiencing excessive hair shedding, thinning hair, or baldness, consulting a qualified physician or dermatologist can help identify the cause and select a safe, appropriate treatment.
Hair loss and thinning can be associated with many factors, including physical illnesses, inherited conditions, hormonal influences, medications, and psychological or physiological stress. To make these conditions easier to understand, we can broadly divide them into two categories.
Two Main Categories of Hair Loss, Thinning Hair, and Baldness
- Hair loss associated with permanent damage to hair follicles (Permanent Hair Follicle Damage): Permanent follicular destruction may occur rapidly following burns, serious injuries, or certain forms of trauma, or develop gradually through scarring disorders of the scalp. In advanced cases, the affected area may no longer produce hair. The original article also discusses androgenetic alopecia (AGA), including male pattern hair loss (MPHL) and female pattern hair loss (FPHL). However, AGA typically involves progressive follicular miniaturization rather than the same destructive scarring process. Early AGA can often respond to medical treatment, while selected patients with established hair loss may consider surgical options such as hair transplantation or, less commonly, scalp reduction surgery.
- Hair loss caused by temporary disruption of the hair growth cycle (Temporary Hair Cycle Disruption): Various factors may interfere with normal hair growth, including severe or chronic stress, postpartum hormonal changes, anemia, influenza and other systemic illnesses, thyroid disorders, chemotherapy, or radiotherapy. In many cases, hair shedding improves when the underlying cause is resolved, although recovery depends on the diagnosis and some treatments may have lasting effects on hair growth.
One of the conditions frequently encountered in clinical practice is androgenetic alopecia, a form of pattern hair loss associated with genetic susceptibility and androgen-related influences. It is commonly recognized in men but also affects women. Because this condition may progress over time, management often requires ongoing assessment and treatment. Nevertheless, it does not mean that improvement is impossible. The results depend on the stage of hair loss, individual health, and response to treatment.
Treatment Options for Androgenetic Hair Loss (MPHL and FPHL)
Group 1: Patients Seeking Hair Restoration in Areas with Advanced or Permanent Hair Loss
For patients with bald areas where functioning hair follicles have been permanently lost or where hair regrowth is unlikely, several options may help restore the appearance of hair coverage. The most appropriate choice depends on the cause and extent of hair loss, the condition of the scalp, the patient's expectations, and their preferred level of maintenance.
- Cosmetic Camouflage Techniques: Non-surgical options include hairpieces, wigs, hair extensions, and scalp micropigmentation (SMP), sometimes called a hair tattoo. These methods can improve the appearance of hair density without restoring functioning hair follicles.
- Surgical Hair Restoration: Selected patients may consider procedures designed to reduce the visible bald area or transplant healthy hair follicles into areas of hair loss.
- Scalp Reduction Surgery: This procedure involves surgically removing part of a bald scalp area and repositioning the surrounding hair-bearing scalp to reduce the visible area of baldness. Suitability depends on the size and location of the bald area, scalp flexibility, and other factors. It is now used selectively rather than being a routine treatment for pattern hair loss.
- Hair Transplantation Surgery (Hair Restoration Surgery): Hair transplantation involves moving follicular units from a suitable donor area, commonly the back or sides of the scalp, into an area affected by hair loss. Donor hair follicles are generally selected because they are relatively resistant to androgen-related miniaturization, although they are not necessarily completely immune to future changes. Two established harvesting techniques are commonly used:
- FUT (Follicular Unit Transplantation): In this method, the surgeon removes a narrow strip of hair-bearing scalp from the donor region. The strip is then carefully dissected into individual follicular unit grafts. These units generally contain approximately one to four hairs, depending on natural hair grouping. Single-hair grafts, and appropriately selected small follicular units, are commonly used along the frontal hairline to create a natural-looking transition, while larger units may be placed in areas requiring greater density.
-
- FUE (Follicular Unit Extraction): This technique involves extracting individual follicular units directly from the donor area, commonly at the back or sides of the scalp, using a specialized punch instrument rather than removing a continuous strip of scalp. FUE produces multiple small extraction sites instead of one linear donor scar. Follicles are harvested in a distributed pattern to help preserve the appearance of donor-area density. However, excessive harvesting can still cause visible donor thinning or scarring. The number of grafts required depends on the recipient area's size, the patient's hair characteristics, and the available donor supply.
Group 2: Patients Seeking to Reduce Hair Loss and Prevent Further Thinning
For patients who want to reduce ongoing hair loss, improve thinning hair, or slow the progression of androgenetic alopecia, medical management may be appropriate. The primary objective is to help maintain existing follicles, reduce further miniaturization, and improve hair density where possible. Treatment may not fully restore areas in which follicles have been permanently lost.
Established Medical Treatment Options
1. Oral Medications: Certain oral medications are used to manage androgenetic hair loss by affecting androgen activity. In particular, 5-alpha-reductase inhibitors reduce the conversion of testosterone into dihydrotestosterone (DHT), a hormone involved in follicular miniaturization among genetically susceptible individuals.
Oral Medications Commonly Discussed for Hair Loss Treatment
For Men: The original article discusses two medications: finasteride, 1 mg daily, and dutasteride, 0.5 mg daily. Both inhibit the formation of DHT, although they differ in their pharmacological properties and regulatory approval for hair loss across countries. The article also mentions effectiveness of up to 70% and noticeable changes after approximately 4–6 months. In clinical practice, treatment response varies, and meaningful assessment often requires several months. Continued treatment is generally needed to maintain benefits, while stopping treatment can allow androgenetic hair loss to progress again. These medications may have adverse effects and are not appropriate for everyone. Dosing and use must be determined by a qualified physician rather than based on this article alone.
For Women: The original article discusses spironolactone, 25 mg daily, as a potential physician-supervised treatment for selected women with pattern hair loss. Spironolactone has antiandrogenic properties and is also a potassium-sparing diuretic. Potential adverse effects include increased blood potassium levels, blood pressure changes, and other medication-related complications. Monitoring may be necessary, particularly in patients with kidney disease, cardiovascular conditions, or those taking interacting medications. It is not appropriate during pregnancy. The dose described here reflects the original article and is not a general prescribing recommendation.
2. Topical Medications: Solutions, Lotions, or Sprays One commonly used treatment is minoxidil, available in topical formulations such as 2% and 5%. The original article describes an approximately 20% response figure and suggests regular use once or twice daily for at least 4–6 months before evaluating results. However, response rates and recommended application schedules depend on the formulation, patient characteristics, and clinical evidence; the 20% figure should not be interpreted as a universal success rate. Possible side effects include scalp irritation, sometimes related to ingredients in the formulation. Patients with existing scalp inflammation or sensitivity should consult their physician before use. If minoxidil is discontinued, its hair-growth benefits generally diminish over time, and hair shedding may recur over subsequent months.
Both oral and topical treatments for androgenetic alopecia generally require continued use to maintain their benefits. Patients should discuss any decision to start, change, or discontinue medication with their physician. Treatment plans should consider the severity of hair loss, potential adverse effects, personal preferences, and the impact of hair loss on quality of life and self-confidence.
Group 3: Additional and Emerging Hair Loss Treatment Options
Additional treatment approaches continue to be explored for patients experiencing hair loss. These procedures may be considered for specific purposes, including:
- Alternative Treatment: For patients who decline conventional medical treatment or are unsuitable for hair transplantation, other approaches may be discussed, provided their evidence, risks, and limitations are clearly explained.
- Adjunctive Treatment: Selected procedures may be considered alongside established treatment for patients who have experienced limited improvement, although additional treatments do not necessarily provide better outcomes and should be evaluated individually.
Examples of procedures currently offered or under investigation include treatments involving growth factors and other biological or injectable preparations:
- Mesotherapy: Injection of selected substances into the scalp. The composition of these preparations varies, and evidence for effectiveness in treating different forms of hair loss remains limited or inconsistent.
- Platelet-Based Treatments: Platelet-rich plasma (PRP) derived from the patient's own blood contains platelets and associated growth factors. Some studies suggest potential benefits for certain patients with androgenetic alopecia, but treatment protocols and clinical results vary.
- Hair Follicle or Cell-Based Approaches: Experimental methods involving cells or biological materials derived from the patient's hair-bearing scalp, often the occipital donor region, are being investigated. These should be distinguished from established hair transplantation because many regenerative cell-based approaches have not yet demonstrated consistent effectiveness or obtained routine regulatory approval.
